Akanda Adjourns Special Meeting of Shareholders
Toronto, Ontario--(Newsfile Corp. - April 29, 2026) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company") today convened and subsequently adjourned its Special Meeting of Shareholders (the "Meeting") without transacting any business due to the absence of a quorum. The Meeting has been adjourned and will be reconvened in person in Toronto, Ontario on Monday, May 25, 2026 at 10:00 a.m. (Eastern Time). The adjournment provides the Company wi
Cannabis, Santé, Cultivateurs de cannabis, Producteurs de cannabis
2026-04-29 8:30 AM EDT | Akanda Corp
Red Light Holland Announces Filament Health Obtains Final Order for Proposed Arrangement
Toronto, Ontario--(Newsfile Corp. - April 29, 2026) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light" or the "Company") and Filament Health Corp. (OTC: FLHLF) ("Filament") are pleased to announce that, further to their joint press release dated March 10, 2026, March 23, 2026 and April 27, 2026, that the Supreme Court of British Columbia has issued a final order (the "Final Order") approving the previously announced acquisition by Red Ligh
Cannabis, Santé, Psychédéliques, Fournisseurs de services auxiliaires liés au cannabis
2026-04-29 7:30 AM EDT | Red Light Holland Corp.
Vext Reports Q4 and FY 2025; Fiscal 2025 Revenue up +43% to $51.4M, Operating Cash Flow up +256% to $11.7M as Ohio Retail Scales
Fiscal 2025 revenue of $51.4 million, up +43% YoY, with EBITDA* of $5 million and Adjusted EBITDA* of $10.9 million; net cash provided by operating activities of $11.7 million, up +256% (+$8.4 million) YoY. Margins expected to improve as newer Ohio retail locations ramp and the retail base continues to stabilize. Q4 2025 revenue of $13.7 million, up +35% YoY; Adjusted EBITDA* of $2.1 million and net cash provided by operating act
Cannabis, Cultivateurs de cannabis, Dispensaires de cannabis, Producteurs de cannabis
2026-04-29 6:30 AM EDT | VEXT Science, Inc.
MustGrow Receives Georgia Registration for TerraSante(TM) Biofertility Product
Saskatoon, Saskatchewan--(Newsfile Corp. - April 28, 2026) - MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGRO
Agriculture, Biotechnologies, Cannabis, Sélectionneurs de cannabis
2026-04-28 7:00 AM EDT | MustGrow Biologics Corp.
Herbal Dispatch Provides Market Update on Launch of First Edible Brand: Chomp Edibles
Vancouver, British Columbia--(Newsfile Corp. - April 28, 2026) - Herbal Dispatch Inc. (CSE: HERB) (OTCQB: LUFFF) (FSE: HA9) ("Herbal Dispatch" or the "Company"), a cannabis e-commerce and distribution platform, today announced the launch of its first dedicated edibles brand, Chomp Edibles ("Chomp"), marking a strategic expansion into one of the fastest-growing segments of the Canadian cannabis market. Chomp represents a focus
Pharmaceutique, Cannabis, Dispensaires de cannabis
2026-04-28 3:01 AM EDT | Herbal Dispatch Inc.
Quinsam Reports Q4/2025 Results
Toronto, Ontario--(Newsfile Corp. - April 27, 2026) - Quinsam Capital Corporation (CSE: QCA) ("Quinsam" or the "Company") is announcing its Q4/2025 results, with net income of $0.4 million ($0.01 per share basic, $0.01 fully diluted) versus a net loss of $4.3 million ($0.04 per share basic, $0.01 fully diluted) in Q4/2024. Investors can access
Services bancaires / financiers, Cannabis, Cultivateurs de cannabis, Fournisseurs de services auxiliaires liés au cannabis
2026-04-27 8:00 AM EDT | Quinsam Capital Corporation
Red Light Holland Announces Filament Health Shareholder Approval of Acquisition
Toronto, Ontario--(Newsfile Corp. - April 27, 2026) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light") and Filament Health Corp. (OTC: FLHLF) ("Filament") are pleased to announce that, further to their joint press release dated March 10, 2026 and March 23, 2026, Filament's shareholders (the "Filament Shareholders") have approved each of the matters voted on at the Filament annual general and special meeting ("Filament Meeting") hel
Cannabis, Santé, Psychédéliques, Fournisseurs de services auxiliaires liés au cannabis
2026-04-27 7:30 AM EDT | Red Light Holland Corp.
Herbal Dispatch Advances U.S. Strategy amid Historic Cannabis Rescheduling Shift
Vancouver, British Columbia--(Newsfile Corp. - April 27, 2026) - Herbal Dispatch Inc. (CSE: HERB) (OTCQB: LUFFF) (FSE: HA9) ("Herbal Dispatch" or the "Company"), provides an update on recent regulatory developments in the United States relating to the proposed rescheduling of cannabis under the Controlled Substances Act. The U.S. Department of Health and Human Services has recommended that cannabis be reclassified from Schedule I to Schedule III, a move th
Pharmaceutique, Cannabis, Dispensaires de cannabis
2026-04-27 3:01 AM EDT | Herbal Dispatch Inc.
Red Light Holland Showcases Growing Clinical Demand for Filament Health's PEX010 with New and Repeat University Shipments
Toronto, Ontario--(Newsfile Corp. - April 24, 2026) - Red Light Holland Corp. (CSE: TRIP) (OTCQB: TRUFF) (FSE: 4YX) ("Red Light" or the "Company") is pleased to highlight continued expansion and execution of clinical supply shipments of PEX010, a botanical psilocybin drug candidate developed by Filament Health Corp., to leading Canadian research institutions. Following its press release dated April 7, 2026, Red Light is highlighting recent accomplishments and ongoing momentum, including
Cannabis, Santé, Psychédéliques, Fournisseurs de services auxiliaires liés au cannabis
2026-04-24 8:26 AM EDT | Red Light Holland Corp.
Herbal Dispatch Reports Q4 2025 Gross Sales of $6.2 Million, Achieves Positive Adjusted EBITDA, and Reports Full Year Gross Sales of $16.5 Million
Vancouver, British Columbia--(Newsfile Corp. - April 24, 2026) - Herbal Dispatch Inc. (CSE: HERB) (OTCQB: LUFFF) (FSE: HA9) ("Herbal Dispatch" or the "Company"), announces its financial results for the fourth quarter and year ended December 31, 2025. Q4 2025 HIGHLIGHTS Gross sales of $6.2 million, representing a 115% increase compared to $2.9 million in Q4 2024 Net revenue of $4.1 million (excluding excise
Pharmaceutique, Cannabis, Dispensaires de cannabis
2026-04-24 3:01 AM EDT | Herbal Dispatch Inc.
Psyched Wellness Highlights U.S. Federal Policy Momentum Supporting Psychedelic Sector
Toronto, Ontario--(Newsfile Corp. - April 23, 2026) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company"), a life sciences company focused on the production and distribution of Amanita Muscaria-derived health and wellness products, today highlights recent U.S. federal policy developments supporting psychedelic research and outlines the potential implications for the sector and the Company. Recent announcements by U.S. President Donald Trump include an exec
Cannabis, Santé, Psychédéliques, Producteurs de cannabis
2026-04-23 7:30 AM EDT | Psyched Wellness Ltd.
City View Green Holdings Inc. Announces Non-Brokered Private Placement and Shares for Debt Settlements
Toronto, Ontario--(Newsfile Corp. - April 23, 2026) - City View Green Holdings Inc. (CSE: CVGR) (OTC Pink: CVGRF) (FSE: CVY0) (the "Company" or "City View") announces that it proposes to undertake an up to $500,000 non-brokered private placement (the "Offering") of units (each, a "Unit") to be sold at a price of $0.05 per Unit. Each Unit will consist of one common share of the Company and one common share purchase warrant. Each warrant will entitle the holder to
Aliments / boissons, Cannabis, Extracteurs de cannabis, Producteurs de cannabis
2026-04-23 7:17 AM EDT | City View Green Holdings Inc.
Herbal Dispatch Welcomes the Honourable Herb Dhaliwal as Full-Time Chairman
Vancouver, British Columbia--(Newsfile Corp. - April 23, 2026) - Herbal Dispatch Inc. (CSE: HERB) (OTCQB: LUFFF) (FSE: HA9) ("Herbal Dispatch" or the "Company"), a leading cannabis e-commerce and distribution platform, is pleased to announce the appointment of the Honourable Herb Dhaliwal, PC, as a full-time Board Member and Chairman of the Board. The Honourable Herb Dhaliwal, brings a wealth of experience in public service, business, and leadership to Her
Pharmaceutique, Cannabis, Dispensaires de cannabis
2026-04-23 3:01 AM EDT | Herbal Dispatch Inc.
Delivra Health Brands Enters into Licence Agreement with Peak Processing to Manufacture and Distribute Its Topical Brand LivRelief Infused(TM)
Vancouver, British Columbia--(Newsfile Corp. - April 22, 2026) - Delivra Health Brands Inc. (TSXV: DHB) OTCQB: DHBUF) ("Delivra Health" or the "Company"), a consumer packaged goods company uniquely positioned in the health and wellness sector, announced today that its wholly-owned subsidiary, LivCorp Inc., has entered into a licence agreement ("Licence Agreement") with Peak Processing Solutions ("Peak") (ASX: PKP), to manufacture, distribute and sell infu
Cannabis, Santé, Extracteurs de cannabis, Producteurs de cannabis
2026-04-22 5:45 PM EDT | Delivra Health Brands Inc.
Vext Announces Revised Date for Q4 and Fiscal 2025 Financial Results Release
Vancouver, British Columbia--(Newsfile Corp. - April 21, 2026) - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("Vext" or the "Company") a U.S.-based cannabis operator in Arizona and Ohio, today announced that further to its previous disclosure regarding the timing of its fourth quarter and full year 2025 financial results release and conference call, the Company now expects to release its financial results for the perio
Cannabis, Cultivateurs de cannabis, Dispensaires de cannabis, Producteurs de cannabis
2026-04-21 4:30 PM EDT | VEXT Science, Inc.
Herbal Dispatch Announces Receipt of U.S. DTC Eligibility and Engagement of Market Maker
Vancouver, British Columbia--(Newsfile Corp. - April 21, 2026) - Herbal Dispatch Inc. (CSE: HERB) (OTCQB: LUFFF) (FSE: HA9) ("Herbal Dispatch" or the "Company"), a leading cannabis e-commerce and distribution platform, is pleased to announce that the Company's common shares are now eligible for electronic clearing and settlement through the Depository Trust Company ("DTC"). DTC eligibility significantly enhances accessibility for U.S.-based investor
Pharmaceutique, Cannabis, Dispensaires de cannabis
2026-04-21 3:01 AM EDT | Herbal Dispatch Inc.
Nextleaf Advances Capex-Light Model with New Micro-Processing Site Licence, Supporting Revenue Growth and Margin Expansion
Vancouver, British Columbia--(Newsfile Corp. - April 20, 2026) - Nextleaf Solutions Ltd. (CSE: OILS) (OTCQB: OILFF) (FSE: L0MA) ("Nextleaf", "OILS", or the "Company"), a multi-patented life science company and Canadian cannabis processor, is pleased to announce it has been granted a Health Canada Micro-Processing Licence for its second site of operations, Nextleaf Distribution. The issuance of this licence marks a key milestone in the Company's capex-light expansion strategy stre
Biotechnologies, Pharmaceutique, Cannabis, Extracteurs de cannabis
2026-04-20 9:00 AM EDT | Nextleaf Solutions Ltd.
Red Light Holland Highlights U.S. FDA-Authorized Study Supporting Multi-Session Psilocybin Therapy using Filament Health's Patented PEX010 Botanical Drug Candidate
Study conducted under U.S. FDA Investigational New Drug (IND) authorization by Dr. Anthony Back at the University of Washington Second psilocybin session showed meaningful improvements in anxiety, depression, and overall psychological outcomes, with effects lasting up to 24 weeks 69% of participants fell below clinical thresholds for anxiety and depression after second treatment Research builds on prior studies utilizing Filament's botanica
Cannabis, Santé, Psychédéliques, Fournisseurs de services auxiliaires liés au cannabis
2026-04-20 7:30 AM EDT | Red Light Holland Corp.
PharmaCielo Announces Intention to Issue Interest Shares
Ontario and Rionegro, Colombia--(Newsfile Corp. - April 17, 2026) - PharmaCielo Ltd. (TSXV: PCLO) (OTC Pink: PCLOF) ("PharmaCielo" or the "Company"), the Canadian parent of Colombia's premier cultivator and producer of dried flower and food and medicinal grade cannabis extracts for the natural pharmaceuticals and consumer products market, PharmaCielo
Cannabis, Extracteurs de cannabis
2026-04-17 7:30 AM EDT | PharmaCielo Ltd.
Cardiol Therapeutics to Highlight MAVERIC Phase III Trial and Recently Published ARCHER Results in Live Interview with Barchart
Toronto, Ontario--(Newsfile Corp. - April 14, 2026) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a late-stage life sciences company focused on advancing the development of anti-inflammatory and anti-fibrotic therapies for heart disease, is pleased to announce that Cardiol's President and Chief Executive Officer, David Elsley, will participate in a live interview on X with
Biotechnologies, Cannabis, Santé, Producteurs de cannabis
2026-04-14 7:27 AM EDT | Cardiol Therapeutics Inc.